Private Market View

Abridge

Enterprise Systems (Healthcare) · Pittsburgh, PA · Founded 2018 · Privately Held (backing)

PA Mark · $/share
$165
Sep 2026
Implied valuation
$6.6B
Total raised
$758.0M
Last round
Later Stage VC (Series D)
Feb 2025
What is Abridge worth?
$6.6Blast known valuation

Abridge last raised $250.0M in its Later Stage VC (Series D) (Feb 2025).

Free account
See the evidence behind this price
  • ·Post-money valuations for all 3 rounds
  • ·The complete investor list — 50 names
  • ·Watchlist + deal alerts for Abridge
Create free account
No card required

Funding history

3 rounds
DateRoundRaisedPost-money
Feb 2025Later Stage VC (Series D)$250.0M
Feb 2024Later Stage VC (Series C)$150.0M
Oct 2023Later Stage VC (Series B)$30.0M

How Abridge's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Abridge, we compose those signals into the PA Mark — a weighted composite of 1 recent pricing inputs, decayed by age and reset on new rounds. The implied valuation multiplies the mark by shares outstanding. Full methodology →

Frequently asked

What is Abridge worth?
Abridge's implied valuation is $6.6B, based on the PA Mark composite price of about $165 per share as of Sep 2026.
How much has Abridge raised?
Abridge has raised $758.0M in total funding across 3 recorded rounds.
When did Abridge last raise?
Abridge last raised in Feb 2025 (Later Stage VC (Series D)), raising $250.0M.